BOULDER, Colo.--(BUSINESS WIRE)--Oct. 31, 2016--
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick
Mahaffy, the Company’s President and CEO, will present at the 2016
Credit Suisse Healthcare Conference on Tuesday, November 8, at 1:00pm
MST. The conference is being held at the Phoenician in Scottsdale,
A live webcast of the corporate presentation at the conference will be
accessible through the investor relations section of the Company’s
website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops diagnostic tools that direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado, and
has additional offices in San Francisco, California and Cambridge, UK.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161031005013/en/
Source: Clovis Oncology
Breanna Burkart, 303-625-5023